Abstract
The primary goals of this last chapter are to: (1) make note of the technologies mentioned earlier in this book, (2) describe some important changes in healthcare and global markets that could have an impact on the use rate of technologies being developed, and (3) discuss several other future opportunities in the cardiac device arena. It should be noted that the chapters of this third edition were updated, and new ones were added to specifically describe recent critical advances in cardiac device technologies and/or clinical applications. There are also other areas of importance in cardiac treatment such as biological approaches to disease management (stem cell therapy), genomics (diagnostics and gene therapy), proteomics, and/or tissue engineering, all of which may have a major impact on the future of cardiac clinical care; however, detailed discussions of these approaches are beyond the scope of this book.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aranoff S (2014) The National Law Review. 29 October 2014. http://www.natlawreview.com/author/shara-aranoff
Kelley TA, Marquez S, Popelar CF (2013) In vitro testing of heart valve substitutes. In: Iaizzo PA, Bianco RW, Hill AJ, St Louis JD (eds) Heart valves: from design to clinical implantation. Springer, New York, pp 283–320
Santini M, Ricci RP (2006) The worldwide social burden of atrial fibrillation: what should be done and where do we go? J Interv Card Electrophysiol 17:183–188
Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569–582
Anversa P, Olivetti G, Capasso JM (1991) Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68:7D–16D
Saaverda WF, Tunin RS, Paolocci N et al (2002) Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol 39:2069–2076
Francis GS (2001) Pathophysiology of chronic heart failure. Am J Med 110:37S–46S
REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor Clinician Manual. http://manuals.medtronic.com/wcm/groups/mdtcom_sg/@emanuals/@era/@crdm/documents/documents/contrib_185856.pdf
Laske TG, Garshelis DL, Iaizzo PA (2014) Big data in wildlife research: remote web-based monitoring of hibernating black bears. BMC Physiol 14:13
Website Sources (All Websites Were Accessed on December 27, 2014)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Iaizzo, P.A. (2015). Cardiac Devices and Technologies: Continued Rapid Rates of Development. In: Iaizzo, P. (eds) Handbook of Cardiac Anatomy, Physiology, and Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-19464-6_44
Download citation
DOI: https://doi.org/10.1007/978-3-319-19464-6_44
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19463-9
Online ISBN: 978-3-319-19464-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)